In this study, we demonstrated that genetic deletion of IP3R1 within cerebellum and brainstem is sufficient to cause dystonia in mice, and that further pharmacological inactivation of the cerebellum or the IO and deletion of PCs ameliorate the dyskinesia. Here, ITPR1 is linked to drug-induced dyskinesia.